Goda K, Kenzaka T, Kuriyama K, Hoshijima M, Akita H. End-of-life home care of an interstitial pneumonia patient supported by high-flow nasal cannula therapy: A case report. World J Clin Cases 2020; 8(20): 4853-4857 [PMID: 33195653 DOI: 10.12998/wjcc.v8.i20.4853]
Corresponding Author of This Article
Tsuneaki Kenzaka, MD, PhD, Professor, Division of Community Medicine and Career Development, Kobe University Graduate School of Medicine, 2-1-5, Arata-cho, Hyogo-ku, Kobe 652-0032, Japan. smile.kenzaka@jichi.ac.jp
Research Domain of This Article
Medicine, General & Internal
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Oct 26, 2020; 8(20): 4853-4857 Published online Oct 26, 2020. doi: 10.12998/wjcc.v8.i20.4853
End-of-life home care of an interstitial pneumonia patient supported by high-flow nasal cannula therapy: A case report
Ken Goda, Tsuneaki Kenzaka, Kyosuke Kuriyama, Masahiko Hoshijima, Hozuka Akita
Ken Goda, Tsuneaki Kenzaka, Masahiko Hoshijima, Hozuka Akita, Department of Internal Medicine, Hyogo Prefectural Tamba Medical Center, Tamba 669-3495, Japan
Ken Goda, Tsuneaki Kenzaka, Division of Community Medicine and Career Development, Kobe University Graduate School of Medicine, Kobe 652-0032, Japan
Ken Goda, Tsuneaki Kenzaka, Department of Medicine, Tamba City mirune Clinic, Tamba 669-3464, Japan
Kyosuke Kuriyama, Clinical Engineer, Nursing Department, Hyogo Prefectural Tamba Medical Center, Tamba 669-3495, Japan
Author contributions: Goda K managed the case and prepared and revised the manuscript; Kenzaka T assisted with manuscript preparation, correction, and revision; Kuriyama K and Hoshijima M managed the case and assisted with manuscript preparation, correction, and revision; Akita H assisted with manuscript preparation, correction, and revision. All authors have read and approved the final version of the manuscript.
Informed consent statement: Written informed consent was obtained from the patient’s wife for the publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor of this journal.
Conflict-of-interest statement: The authors declare that they have no competing interests.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Tsuneaki Kenzaka, MD, PhD, Professor, Division of Community Medicine and Career Development, Kobe University Graduate School of Medicine, 2-1-5, Arata-cho, Hyogo-ku, Kobe 652-0032, Japan. smile.kenzaka@jichi.ac.jp
Received: August 24, 2020 Peer-review started: August 24, 2020 First decision: September 13, 2020 Revised: September 18, 2020 Accepted: September 25, 2020 Article in press: September 25, 2020 Published online: October 26, 2020 Processing time: 63 Days and 6.2 Hours
Abstract
BACKGROUND
High-flow nasal cannula (HFNC) therapy and morphine continuous subcutaneous infusion (CSI) have been used to ameliorate dyspnea in non-cancer patients with end-stage respiratory diseases, including chronic obstructive pulmonary disease and interstitial pneumonia, primarily in hospital settings. However, it is rare to perform home-based medical treatment using these. We observe a case to assess the feasibility of this treatment strategy.
CASE SUMMARY
Here, we report a case of a 75-year-old man who was diagnosed with interstitial pneumonia 11 years ago and was successfully nursed at home during his terminal phase for over 10 mo without hospitalization, by introducing domiciliary uses of HFNC and morphine CSI with a patient-controlled analgesia device.
CONCLUSION
Active utilization of HFNC and morphine CSI with patient-controlled analgesia device would substantiate successful end-of-life palliative home care of idiopathic interstitial pneumonia patients.
Core Tip: We propose that active utilization of high-flow nasal cannula and morphine continuous subcutaneous infusion with a patient-controlled analgesia device would substantiate successful palliative care of patients with idiopathic interstitial pneumonia at home, nearing their end-of-life.
